A detailed history of Rhumbline Advisers transactions in Elanco Animal Health Inc stock. As of the latest transaction made, Rhumbline Advisers holds 479,229 shares of ELAN stock, worth $6.7 Million. This represents 0.01% of its overall portfolio holdings.

Number of Shares
479,229
Previous 481,069 0.38%
Holding current value
$6.7 Million
Previous $6.94 Million 1.35%
% of portfolio
0.01%
Previous 0.01%

Shares

24 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Nov 12, 2024

SELL
$11.85 - $15.47 $21,804 - $28,464
-1,840 Reduced 0.38%
479,229 $7.04 Million
Q2 2024

Aug 01, 2024

SELL
$12.93 - $18.45 $195,592 - $279,093
-15,127 Reduced 3.05%
481,069 $6.94 Million
Q1 2024

May 09, 2024

SELL
$14.37 - $16.46 $985,408 - $1.13 Million
-68,574 Reduced 12.14%
496,196 $8.08 Million
Q4 2023

Feb 08, 2024

BUY
$8.6 - $14.94 $22,016 - $38,246
2,560 Added 0.46%
564,770 $8.42 Million
Q3 2023

Nov 09, 2023

SELL
$9.81 - $12.62 $13,792 - $17,743
-1,406 Reduced 0.25%
562,210 $6.32 Million
Q2 2023

Aug 08, 2023

BUY
$8.08 - $10.37 $669,347 - $859,050
82,840 Added 17.23%
563,616 $5.67 Million
Q1 2023

May 11, 2023

SELL
$8.79 - $14.58 $82,406 - $136,687
-9,375 Reduced 1.91%
480,776 $4.52 Million
Q4 2022

Feb 14, 2023

BUY
$11.49 - $13.65 $271,508 - $322,549
23,630 Added 5.07%
490,151 $5.99 Million
Q3 2022

Nov 10, 2022

BUY
$12.41 - $32.42 $292,416 - $763,912
23,563 Added 5.32%
466,521 $5.79 Million
Q2 2022

Aug 11, 2022

BUY
$19.63 - $26.62 $1.34 Million - $1.82 Million
68,239 Added 18.21%
442,958 $8.7 Million
Q1 2022

May 12, 2022

BUY
$24.65 - $29.0 $453,239 - $533,223
18,387 Added 5.16%
374,719 $9.78 Million
Q4 2021

Feb 10, 2022

BUY
$27.74 - $34.09 $300,340 - $369,092
10,827 Added 3.13%
356,332 $10.1 Million
Q3 2021

Nov 12, 2021

SELL
$29.2 - $36.72 $956,708 - $1.2 Million
-32,764 Reduced 8.66%
345,505 $11 Million
Q2 2021

Aug 05, 2021

SELL
$28.76 - $35.98 $653,024 - $816,961
-22,706 Reduced 5.66%
378,269 $13.1 Million
Q1 2021

May 06, 2021

SELL
$27.85 - $34.49 $961,493 - $1.19 Million
-34,524 Reduced 7.93%
400,975 $11.8 Million
Q4 2020

Feb 10, 2021

BUY
$27.53 - $33.79 $1.52 Million - $1.86 Million
55,059 Added 14.47%
435,499 $13.4 Million
Q3 2020

Nov 12, 2020

SELL
$21.1 - $29.13 $649,373 - $896,504
-30,776 Reduced 7.48%
380,440 $10.6 Million
Q2 2020

Aug 13, 2020

BUY
$18.94 - $24.93 $228,681 - $301,004
12,074 Added 3.02%
411,216 $8.82 Million
Q1 2020

May 06, 2020

BUY
$16.68 - $32.25 $830,230 - $1.61 Million
49,774 Added 14.25%
399,142 $8.94 Million
Q4 2019

Feb 05, 2020

BUY
$25.29 - $29.45 $157,759 - $183,709
6,238 Added 1.82%
349,368 $10.3 Million
Q3 2019

Oct 23, 2019

BUY
$25.62 - $34.96 $267,472 - $364,982
10,440 Added 3.14%
343,130 $9.12 Million
Q2 2019

Aug 14, 2019

BUY
$31.11 - $34.79 $1.16 Million - $1.3 Million
37,389 Added 12.66%
332,690 $11.2 Million
Q1 2019

May 01, 2019

BUY
$29.0 - $32.83 $6.57 Million - $7.44 Million
226,516 Added 329.31%
295,301 $9.47 Million
Q4 2018

Jan 31, 2019

BUY
$29.63 - $34.5 $2.04 Million - $2.37 Million
68,785 New
68,785 $2.17 Million

Others Institutions Holding ELAN

About Elanco Animal Health Inc


  • Ticker ELAN
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 474,113,984
  • Market Cap $6.63B
  • Description
  • Elanco Animal Health Incorporated, an animal health company, innovates, develops, manufactures, and markets products for pets and farm animals. It offers pet health disease prevention products, such as parasiticide and vaccine products that protect pets from worms, fleas, and ticks under the Seresto, Advantage, Advantix, and Advocate brands; pet...
More about ELAN
Track This Portfolio

Track Rhumbline Advisers Portfolio

Follow Rhumbline Advisers and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Rhumbline Advisers, based on Form 13F filings with the SEC.

News

Stay updated on Rhumbline Advisers with notifications on news.